Renaissance Capital logo

Acutus Medical Priced, Nasdaq: AFIB

Manufactures devices for electrophysiological mapping to treat arrhythmias.

Industry: Health Care

Latest Trade: $24.89 0.00 (0.0%)

First Day Return: +47.2%

Return from IPO: +38.3%

Industry: Health Care

We are an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Despite several decades of efforts by incumbents in this field, the clinical and economic challenges associated with arrhythmia treatment continue to be a huge burden for patients, providers and payors. We are committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, we have established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products. Our goal is to provide our customers with a complete solution for catheter-based treatment of cardiac arrhythmias in each of our geographic markets. We design, manufacture and market a range of tools for catheter-based ablation procedures to treat various arrhythmias. Our foundational and most highly differentiated product is our AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias with unmatched speed and precision.
more less
IPO News for Acutus Medical
more
IPO Data
IPO File Date 07/15/2020
Offer Price $18.00
Price Range $16.00 - $18.00
Offer Shares (mm) 8.8
Deal Size ($mm) $159
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 08/05/2020
Offer Price $18.00
Price Range $16.00 - $18.00
Offer Shares (mm) 8.8
Deal Size ($mm) $159
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Carlsbad, CA
Founded 2011
Employees 224
Website www.acutusmedical.com